Clinical Trial Update: BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

View source ↗

Summary

A completed clinical trial evaluates user preference and product claims for the BD FlowSmart Subcutaneous Insulin Infusion Set used in Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BD FlowSmart Subcutaneous Insulin Infusion Set

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Type 1 Diabetes Mellitus | Status: COMPLETED